{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:07:00Z","timestamp":1768964820052,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472810"],"award-info":[{"award-number":["82472810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273183 and 82072683"],"award-info":[{"award-number":["82273183 and 82072683"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Guangdong Province of China","award":["2021A1515011028 and 2022A1515011739"],"award-info":[{"award-number":["2021A1515011028 and 2022A1515011739"]}]},{"name":"Natural Science Foundation of Guangdong Province of China","award":["2022A1515010925"],"award-info":[{"award-number":["2022A1515010925"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04069-2","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T17:36:04Z","timestamp":1765906564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phosphorylated NCOA6 promotes aggressiveness and contributes patient outcomes in estrogen receptor-positive breast cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Hongmei","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiheng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xijiao","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunlong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yexi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shegan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"1","key":"4069_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"4069_CR2","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1038\/s41401-023-01116-4","volume":"44","author":"B Zhang","year":"2023","unstructured":"Zhang B, Xie SH, Hu JY, Lei SJ, Shen LH, Liu HT, et al. Truncated SCRIB isoform promotes breast cancer metastasis through HNRNP A1 mediated exon 16 skipping. Acta Pharmacol Sin. 2023;44(11):2307\u201321.","journal-title":"Acta Pharmacol Sin"},{"issue":"6797","key":"4069_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747\u201352.","journal-title":"Nature"},{"issue":"1","key":"4069_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers. 2019;5(1):66.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4069_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1210\/mend.16.1.0755","volume":"16","author":"L Ko","year":"2002","unstructured":"Ko L, Cardona GR, Iwasaki T, Bramlett KS, Burris TP, Chin WW. Ser-884 adjacent to the LXXLL motif of coactivator TRBP defines selectivity for ERs and TRs. Mol Endocrinol. 2002;16(1):128\u201340.","journal-title":"Mol Endocrinol"},{"key":"4069_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22157812","author":"C Hernando","year":"2021","unstructured":"Hernando C, Ortega-Morillo B, Tapia M, Moragon S, Martinez MT, Eroles P, et al. Oral selective estrogen receptor degraders (SERDs) as a novel breast cancer therapy: present and future from a clinical perspective. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22157812.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4069_CR7","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1373\/clinchem.2009.125377","volume":"55","author":"MJ Higgins","year":"2009","unstructured":"Higgins MJ, Stearns V. Understanding resistance to Tamoxifen in hormone receptor-positive breast cancer. Clin Chem. 2009;55(8):1453\u20135.","journal-title":"Clin Chem"},{"issue":"3","key":"4069_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10549-013-2699-3","volume":"141","author":"G Ciriello","year":"2013","unstructured":"Ciriello G, Sinha R, Hoadley KA, Jacobsen AS, Reva B, Perou CM, et al. The molecular diversity of luminal A breast tumors. Breast Cancer Res Treat. 2013;141(3):409\u201320.","journal-title":"Breast Cancer Res Treat"},{"issue":"48","key":"4069_CR9","doi-asserted-by":"publisher","first-page":"34283","DOI":"10.1074\/jbc.274.48.34283","volume":"274","author":"SK Lee","year":"1999","unstructured":"Lee SK, Anzick SL, Choi JE, Bubendorf L, Guan XY, Jung YK, et al. A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J Biol Chem. 1999;274(48):34283\u201393.","journal-title":"J Biol Chem"},{"issue":"4","key":"4069_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.14348\/molcells.2022.2222","volume":"45","author":"GS Oh","year":"2022","unstructured":"Oh GS, Kim SR, Lee ES, Yoon J, Shin MK, Ryu HK, et al. Regulation of hepatic gluconeogenesis by nuclear receptor coactivator 6. Mol Cells. 2022;45(4):180\u201392.","journal-title":"Mol Cells"},{"issue":"5","key":"4069_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7150\/ijbs.7.505","volume":"7","author":"Q Li","year":"2011","unstructured":"Li Q, Xu J. Identification and characterization of the alternatively spliced nuclear receptor coactivator-6 isoforms. Int J Biol Sci. 2011;7(5):505\u201316.","journal-title":"Int J Biol Sci"},{"key":"4069_CR12","doi-asserted-by":"publisher","DOI":"10.1621\/nrs.06002","volume":"6","author":"MA Mahajan","year":"2008","unstructured":"Mahajan MA, Samuels HH. Nuclear receptor coactivator\/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development. Nucl Recept Signal. 2008;6:e002.","journal-title":"Nucl Recept Signal"},{"issue":"4","key":"4069_CR13","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.devcel.2012.09.002","volume":"23","author":"J Kawagoe","year":"2012","unstructured":"Kawagoe J, Li Q, Mussi P, Liao L, Lydon JP, DeMayo FJ, et al. Nuclear receptor coactivator-6 attenuates uterine estrogen sensitivity to permit embryo implantation. Dev Cell. 2012;23(4):858\u201365.","journal-title":"Dev Cell"},{"issue":"51","key":"4069_CR14","doi-asserted-by":"publisher","first-page":"19667","DOI":"10.1074\/jbc.RA119.010704","volume":"294","author":"Z Tong","year":"2019","unstructured":"Tong Z, Liu Y, Yu X, Martinez JD, Xu J. The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERalpha and enhancing enhancer-promoter interactions. J Biol Chem. 2019;294(51):19667\u201382.","journal-title":"J Biol Chem"},{"issue":"9","key":"4069_CR15","doi-asserted-by":"publisher","first-page":"e12876","DOI":"10.1111\/cpr.12876","volume":"53","author":"L Wu","year":"2020","unstructured":"Wu L, Zhao KQ, Wang W, Cui LN, Hu LL, Jiang XX, Shuai J, Sun YP. Nuclear receptor coactivator 6 promotes HTR-8\/SVneo cell invasion and migration by activating NF-kappaB-mediated MMP9 transcription. Cell Prolif. 2020;53(9):e12876.","journal-title":"Cell Prolif"},{"issue":"17","key":"4069_CR16","doi-asserted-by":"publisher","first-page":"18425","DOI":"10.1002\/cam4.6427","volume":"12","author":"X Wang","year":"2023","unstructured":"Wang X, Jia Y, Xu X, Hu Y, Fan G, Jing D, et al. Nuclear receptor coactivator 6 (NCoA6) promotes cell proliferation, migration, and invasion in pancreatic cancer. Cancer Med. 2023;12(17):18425\u201339.","journal-title":"Cancer Med"},{"issue":"1","key":"4069_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/cas.15577","volume":"114","author":"Y Fang","year":"2023","unstructured":"Fang Y, Xu Y, Liao W, Ji T, Yu L, Li L, et al. Multiomics analyses and machine learning of nuclear receptor coactivator 6 reveal its essential role in hepatocellular carcinoma. Cancer Sci. 2023;114(1):75\u201390.","journal-title":"Cancer Sci"},{"issue":"14","key":"4069_CR18","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1091\/mbc.e09-12-1031","volume":"21","author":"WL Wang","year":"2010","unstructured":"Wang WL, Li Q, Xu J, Cvekl A. Lens fiber cell differentiation and denucleation are disrupted through expression of the N-terminal nuclear receptor box of NCOA6 and result in p53-dependent and p53-independent apoptosis. Mol Biol Cell. 2010;21(14):2453\u201368.","journal-title":"Mol Biol Cell"},{"issue":"19","key":"4069_CR19","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.1158\/0008-5472.CAN-04-1176","volume":"64","author":"H Zhang","year":"2004","unstructured":"Zhang H, Kuang SQ, Liao L, Zhou S, Xu J. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice. Cancer Res. 2004;64(19):7169\u201377.","journal-title":"Cancer Res"},{"issue":"11","key":"4069_CR20","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1128\/MCB.24.11.4994-5004.2004","volume":"24","author":"MA Mahajan","year":"2004","unstructured":"Mahajan MA, Das S, Zhu H, Tomic-Canic M, Samuels HH. The nuclear hormone receptor coactivator NRC is a pleiotropic modulator affecting growth, development, apoptosis, reproduction, and wound repair. Mol Cell Biol. 2004;24(11):4994\u20135004.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"4069_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2006.09.026","volume":"127","author":"JV Olsen","year":"2006","unstructured":"Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006;127(3):635\u201348.","journal-title":"Cell"},{"key":"4069_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev.bi.58.070189.002321","volume":"58","author":"P Cohen","year":"1989","unstructured":"Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem. 1989;58:453\u2013508.","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"4069_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","volume":"40","author":"F Ardito","year":"2017","unstructured":"Ardito F, Giuliani M, Perrone D, Troiano G, Lo Muzio L. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review). Int J Mol Med. 2017;40(2):271\u201380.","journal-title":"Int J Mol Med"},{"issue":"3","key":"4069_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1210\/er.2004-0018","volume":"26","author":"RC Wu","year":"2005","unstructured":"Wu RC, Smith CL, O\u2019Malley BW. Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr Rev. 2005;26(3):393\u20139.","journal-title":"Endocr Rev"},{"issue":"6","key":"4069_CR25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.molcel.2004.08.019","volume":"15","author":"C Wu","year":"2004","unstructured":"Wu C, Qin J, Yi P, Wong J, Tsai Y, Tsai J, et al. Selective phosphorylations of the SRC-3\/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell. 2004;15(6):937\u201349.","journal-title":"Mol Cell"},{"issue":"8","key":"4069_CR26","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1074\/jbc.275.8.5308","volume":"275","author":"F Caira","year":"2000","unstructured":"Caira F, Antonson P, Pelto-Huikko M, Treuter E, Gustafsson JA. Cloning and characterization of RAP250, a novel nuclear receptor coactivator. J Biol Chem. 2000;275(8):5308\u201317.","journal-title":"J Biol Chem"},{"issue":"11","key":"4069_CR27","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1073\/pnas.97.11.6212","volume":"97","author":"L Ko","year":"2000","unstructured":"Ko L, Cardona GR, Chin WW. Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator. Proc Natl Acad Sci USA. 2000;97(11):6212\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"4069_CR28","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1128\/MCB.20.14.5048-5063.2000","volume":"20","author":"MA Mahajan","year":"2000","unstructured":"Mahajan MA, Samuels HH. A new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB-binding protein. Mol Cell Biol. 2000;20(14):5048\u201363.","journal-title":"Mol Cell Biol"},{"issue":"23","key":"4069_CR29","doi-asserted-by":"publisher","first-page":"8073","DOI":"10.1128\/MCB.00451-07","volume":"27","author":"Q Li","year":"2007","unstructured":"Li Q, Chu MJ, Xu J. Tissue- and nuclear receptor-specific function of the C-terminal LXXLL motif of coactivator NCoA6\/AIB3 in mice. Mol Cell Biol. 2007;27(23):8073\u201386.","journal-title":"Mol Cell Biol"},{"key":"4069_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.838171","volume":"13","author":"H Dong","year":"2022","unstructured":"Dong H, Du L, Cai S, Lin W, Chen C, Still M, et al. Tyrosine phosphatase PTPRO deficiency in ERBB2-positive breast cancer contributes to poor prognosis and lapatinib resistance. Front Pharmacol. 2022;13:838171.","journal-title":"Front Pharmacol"},{"key":"4069_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101118","volume":"76","author":"L Wang","year":"2024","unstructured":"Wang L, Lin Y, Yao Z, Babu N, Lin W, Chen C, et al. Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases. Drug Resist Updat. 2024;76:101118.","journal-title":"Drug Resist Updat"},{"issue":"3","key":"4069_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000351692","volume":"8","author":"M Untch","year":"2013","unstructured":"Untch M, Gerber B, Harbeck N, Jackisch C, Marschner N, Mobus V, von Minckwitz G, Loibl S, Beckmann MW, Blohmer JU, et al. 13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a German team of experts (zurich 2013). Breast Care (Basel). 2013;8(3):221\u20139.","journal-title":"Breast Care (Basel)"},{"key":"4069_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216283","volume":"567","author":"H Dong","year":"2023","unstructured":"Dong H, Lin W, Du L, Yao Z, Li F, Chen S, et al. PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET. Cancer Lett. 2023;567:216283.","journal-title":"Cancer Lett"},{"issue":"3","key":"4069_CR34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/onc.2016.213","volume":"36","author":"H Dong","year":"2017","unstructured":"Dong H, Ma L, Gan J, Lin W, Chen C, Yao Z, et al. PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2. Oncogene. 2017;36(3):410\u201322.","journal-title":"Oncogene"},{"issue":"2","key":"4069_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ng1094-155","volume":"8","author":"XY Guan","year":"1994","unstructured":"Guan XY, Meltzer PS, Dalton WS, Trent JM. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat Genet. 1994;8(2):155\u201361.","journal-title":"Nat Genet"},{"issue":"25","key":"4069_CR36","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.3748\/wjg.v23.i25.4480","volume":"23","author":"M Triki","year":"2017","unstructured":"Triki M, Lapierre M, Cavailles V, Mokdad-Gargouri R. Expression and role of nuclear receptor coregulators in colorectal cancer. World J Gastroenterol. 2017;23(25):4480\u201390.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4069_CR37","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1158\/1055-9965.EPI-14-1426","volume":"24","author":"DC Gibbs","year":"2015","unstructured":"Gibbs DC, Orlow I, Kanetsky PA, Luo L, Kricker A, Armstrong BK, et al. Inherited genetic variants associated with occurrence of multiple primary melanoma. Cancer Epidemiol Biomarkers Prev. 2015;24(6):992\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5328","key":"4069_CR38","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1126\/science.277.5328.965","volume":"277","author":"SL Anzick","year":"1997","unstructured":"Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 1997;277(5328):965\u20138.","journal-title":"Science"},{"issue":"10","key":"4069_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140011","volume":"10","author":"X Song","year":"2015","unstructured":"Song X, Zhang C, Zhao M, Chen H, Liu X, Chen J, et al. Steroid receptor coactivator-3 (SRC-3\/AIB1) as a novel therapeutic target in triple negative breast cancer and its inhibition with a phospho-bufalin prodrug. PLoS One. 2015;10(10):e0140011.","journal-title":"PLoS One"},{"issue":"21","key":"4069_CR40","doi-asserted-by":"publisher","first-page":"9687","DOI":"10.1128\/MCB.25.21.9687-9699.2005","volume":"25","author":"P Yi","year":"2005","unstructured":"Yi P, Wu RC, Sandquist J, Wong J, Tsai SY, Tsai MJ, Means AR, O\u2019Malley BW. Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3\/AIB1). Mol Cell Biol. 2005;25(21):9687\u201399.","journal-title":"Mol Cell Biol"},{"key":"4069_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.steroids.2014.06.008","volume":"90","author":"Q Feng","year":"2014","unstructured":"Feng Q, O\u2019Malley BW. Nuclear receptor modulation\u2013role of coregulators in selective estrogen receptor modulator (SERM) actions. Steroids. 2014;90:39\u201343.","journal-title":"Steroids"},{"issue":"21","key":"4069_CR42","doi-asserted-by":"publisher","first-page":"6580","DOI":"10.1128\/MCB.00118-08","volume":"28","author":"AS Oh","year":"2008","unstructured":"Oh AS, Lahusen JT, Chien CD, Fereshteh MP, Zhang X, Dakshanamurthy S, et al. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1\/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells. Mol Cell Biol. 2008;28(21):6580\u201393.","journal-title":"Mol Cell Biol"},{"issue":"14","key":"4069_CR43","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1128\/MCB.20.14.5041-5047.2000","volume":"20","author":"J Font de Mora","year":"2000","unstructured":"Font de Mora J, Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the Estrogen receptor. Mol Cell Biol. 2000;20(14):5041\u20137.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"4069_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1158\/1078-0432.CCR-14-3277","volume":"22","author":"W Zwart","year":"2016","unstructured":"Zwart W, Flach KD, Rudraraju B, Abdel-Fatah TM, Gojis O, Canisius S, et al. SRC3 phosphorylation at serine 543 is a positive independent prognostic factor in ER-positive breast cancer. Clin Cancer Res. 2016;22(2):479\u201391.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4069_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02032-1","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Wang Y, Jing Y, Zhu Y, Huang X, Wang J, et al. Visualization analysis of breast cancer-related ubiquitination modifications over the past two decades. Discover Oncol. 2025;16(1):431.","journal-title":"Discover Oncol"},{"key":"4069_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1482927","volume":"15","author":"Y Jing","year":"2024","unstructured":"Jing Y, Huang X, Wang Y, Wang J, Li Y, Yelihamu D, et al. Diagnostic value of 5 miRNAs combined detection for breast cancer. Front Genet. 2024;15:1482927.","journal-title":"Front Genet"},{"issue":"1","key":"4069_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-01990-w","volume":"16","author":"X Huang","year":"2025","unstructured":"Huang X, Wang Y, Wang J, Jing Y, Dilraba E, Li Y, et al. Association of DBNDD1 with prognostic and immune biomarkers in invasive breast cancer. Discover Oncol. 2025;16(1):218.","journal-title":"Discover Oncol"},{"issue":"7","key":"4069_CR48","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.21037\/tcr-23-34","volume":"12","author":"Z Luo","year":"2023","unstructured":"Luo Z, Wang Y, Bi X, Ismtula D, Wang H, Guo C. Cytokine-induced apoptosis inhibitor 1: a comprehensive analysis of potential diagnostic, prognosis, and immune biomarkers in invasive breast cancer. Transl Cancer Res. 2023;12(7):1765\u201386.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"4069_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02226-9","volume":"24","author":"L Luo","year":"2025","unstructured":"Luo L, Yang P, Mastoraki S, Rao X, Wang Y, Kettner NM, et al. Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4\/6 inhibition in patients with HR+\/HER2-\u00a0metastatic breast cancer. Mol Cancer. 2025;24(1):48.","journal-title":"Mol Cancer"},{"issue":"9","key":"4069_CR50","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.bbamcr.2016.05.006","volume":"1863","author":"ES Ali","year":"2016","unstructured":"Ali ES, Hua J, Wilson CH, Tallis GA, Zhou FH, Rychkov GY, et al. The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca(2+) signalling in steatotic hepatocytes. Biochim Biophys Acta. 2016;1863(9):2135\u201346.","journal-title":"Biochim Biophys Acta"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04069-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:22:01Z","timestamp":1768922521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-025-04069-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4069"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04069-2","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical research protocol underwent a thorough ethical assessment and received approval from the Ethics Committee at Shantou University Medical School, documented under IRB No. #04\u2013070.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}